Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas

OBJECTIVES: Endometrial stromal sarcomas (ESS) are rare, accounting for < 1% of all uterine malignancies. Treatment has been guided by small case series and retrospective studies. Endocrine therapy is used in both adjuvant and metastatic settings. Aromatase inhibitors (AIs) are widely used in cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Crowley, Fionnuala, Cadoo, Karen A., Chiang, Sarah, Mandelker, Diana L., Bajwa, Raazi, Iasonos, Alexia, Zhou, Qin C., Miller, Kathryn M., Hensley, Martee L., O'Cearbhaill, Roisin E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011013/
https://www.ncbi.nlm.nih.gov/pubmed/35434239
http://dx.doi.org/10.1016/j.gore.2022.100980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011013/
https://www.ncbi.nlm.nih.gov/pubmed/35434239
http://dx.doi.org/10.1016/j.gore.2022.100980

Ejemplares similares